Antimony

Antimony has been studied in 34 papers since 2016: 34 observational studies in people; 11 in the past year. Its furthest trials in people are at phase 2. The newest paper, Nov 10, 2026: “Associations of serum lead, antimony, chromium, and cobalt with hypertension prevalence among lead-exposed workers: a multi-metal cross-sectional study in Xinjiang, China”.

ExposurePhase 2

34 papers study it12 findingsUpdated

MeSH

1 new paper in 30 daysSee all 33 papers on antimony

At a glance

The findings reach people, from one lab or study. 11 independent labs in 3 countries; 2 trials, none about aging, 2 with no results posted.

“direct association between certain metals (Sb, Cu, Zn) and a 7 % increase in QTc prolongation risk”
The role of mitochondrial dysfunction in the association between trace metals and QTc prolongation in the aged populationThe Science of the total environment2024doi:10.1016/j.scitotenv.2024.175791

1 of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 11 independent labs in 3 countries
  • 1 finding against
  • 2 trials, none about aging, 2 with no results posted
  • Funders: National Natural Science Foundation of China and others
  • Humans33

What did studies of antimony find?

1

Studies of antimony measured one outcome, telomere length.

Telomere length

downin humans1

1 study
  1. Antimony is linked with lower telomere length in humans (highest quartile compared to lowest referent quartile) (-6.11%, 95% CI: -11.04,-1.00).

    Humanshighest quartile compared to lowest referent quartileleukocyte

More on Telomere length

What is antimony linked with?

10

Studies link antimony with 10 measures, among them cognitive impairment, hypertension prevalence and incident cancer.

Cognitive impairment

upin humans1downin humans1OR 0.409

2 studies
  1. Antimony is linked with a higher risk of cognitive impairment in humans.

    Humans

  2. Antimony is linked with a lower risk of cognitive impairment in humans (OR 0.409, 95% CI 0.185-0.906).

    Humansn = 631

More on Cognitive impairment

Hypertension prevalence

upin humans1OR 1.646

1 study
  1. Antimony is associated with hypertension prevalence in humans (Lead-exposed workers in northwestern China) (OR 1.646, 95% CI 1.046–2.630).

    HumansLead-exposed workers in northwestern Chinan = 419

More on Hypertension prevalence

Incident cancer

upin humans1OR 1.72

1 study
  1. Antimony is associated with incident cancer in humans (Single-metal model; not significant after FDR correction (p = 0.133)) (OR 1.72, 95% CI 1.13–2.63 per interquartile-range increase; FDR-adjusted p = 0.133).

    HumansSingle-metal model; not significant after FDR correction (p = 0.133)hairPer interquartile-range increase3 yearsn = 2,120

More on Incident cancer

Lumbar bone mineral density

upin humans1

1 study
  1. Antimony is associated with lumbar bone mineral density in humans.

    Humansn = 3,441

Visceral obesity

upin humans1OR 1.26

1 study
  1. Antimony is associated with visceral obesity in humans (Natural log-transformed urinary antimony concentration) (OR 1.260, 95% CI 1.149–1.383).

    HumansNatural log-transformed urinary antimony concentrationn = 5,794

More on Visceral obesity

Depression

upin humans1OR 1.54

1 study
  1. Antimony is linked with a higher risk of depression in humans (OR: 1.54, 95 % CI: 1.22, 1.93).

    Humans

More on Depression

Long QT syndrome

upin humans1+7% risk

1 study
  1. Antimony is linked with a higher risk of long QT syndrome in humans (mixed trace metal exposure) (+7% risk).

    Humansmixed trace metal exposuren = 6,478

More on Long QT syndrome

Age at menarche

downin humans1

1 study
  1. Antimony is associated with age at menarche in humans (Naturally postmenopausal U.S. women; fully adjusted model) (0.137 years earlier).

    HumansNaturally postmenopausal U.S. women; fully adjusted modelfemalesn = 1,981

Diabetic retinopathy

upin silico1

1 study
  1. Antimony predicts diabetic retinopathy in silico (contribution weight of 1.730632 ± 1.791722).

    In silicourine

More on Diabetic retinopathy

Metabolic syndrome

upin humans1OR 1.61

1 study
  1. Antimony is linked with a higher risk of metabolic syndrome in humans (OR = 1.61, 95% CI = 1.08-2.40).

    Humans

More on Metabolic syndrome

Has antimony been tested in people?

0 of 2 about aging

Yes: 34 observational studies in people have been published, and 2 trials are registered.

In trials

Stopped

  • NCT01380301TerminatedCutaneous leishmaniasis

    Low efficacy rates

Trial sponsors

Latest

Dec 2025: 2Jan 2026: 1Feb 2026: 2Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 1Oct 2026: 1Nov 2026: 110 papers in 12 months
Environmental Research

Airborne metals linked to poorer scores on some thinking tests

Estimated lead exposure was linked to poorer executive function, with an odds ratio of 1.15 for an increase spanning the middle half of exposures.Estimated lead exposure was linked to poorer executive function, with an odds ratio of 1.15 for an increase spanning the middle half of exposures.

Cross-sectional · 45,162 peoplePopulations

See all 33 papers on antimony